{"title":"Risk factors for infection after primary reverse shoulder arthroplasty - A systematic review with meta-analysis","authors":"Girinivasan Chellamuthu , S. Samundeeswari , Thamizhmathi Thangaraju , Saseendar Shanmugasundaram","doi":"10.1016/j.jcot.2024.102833","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Periprosthetic joint infections (PJIs) following primary Reverse Shoulder Arthroplasty (RSA) are associated with significant economic burdens and complications. While numerous reviews have explored PJIs after RSA, a comprehensive analysis of risk factors specifically after primary RSA is lacking.</div></div><div><h3>Objective</h3><div>This systematic review aims to provide a comprehensive summary of the incidence and risk factors associated with PJIs after primary RSA.</div></div><div><h3>Methods</h3><div>Following Cochrane and PRISMA guidelines, a systematic search was conducted across multiple databases. Twenty-five articles meeting inclusion criteria were included for analysis.</div></div><div><h3>Results</h3><div>The incidence of PJIs after primary RSA was found to be 1.4%, with Staphylococcus species and Cutibacterium acne as common pathogens. Eleven modifiable and six non-modifiable risk factors were identified. Modifiable factors included pathological weight loss, obesity, metabolic syndrome, and steroid injections within one month before RSA. Non-modifiable factors included a history of previous shoulder surgery, inflammatory arthritis, male sex, and younger age.</div></div><div><h3>Conclusion</h3><div>Proactive management of modifiable risk factors and careful consideration of non-modifiable factors are essential in reducing PJIs after primary RSA. Strategies such as optimizing systemic health conditions and implementing meticulous surgical techniques may contribute to improved outcomes and reduced infection rates in RSA patients.</div></div>","PeriodicalId":53594,"journal":{"name":"Journal of Clinical Orthopaedics and Trauma","volume":"60 ","pages":"Article 102833"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Orthopaedics and Trauma","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0976566224005022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Periprosthetic joint infections (PJIs) following primary Reverse Shoulder Arthroplasty (RSA) are associated with significant economic burdens and complications. While numerous reviews have explored PJIs after RSA, a comprehensive analysis of risk factors specifically after primary RSA is lacking.
Objective
This systematic review aims to provide a comprehensive summary of the incidence and risk factors associated with PJIs after primary RSA.
Methods
Following Cochrane and PRISMA guidelines, a systematic search was conducted across multiple databases. Twenty-five articles meeting inclusion criteria were included for analysis.
Results
The incidence of PJIs after primary RSA was found to be 1.4%, with Staphylococcus species and Cutibacterium acne as common pathogens. Eleven modifiable and six non-modifiable risk factors were identified. Modifiable factors included pathological weight loss, obesity, metabolic syndrome, and steroid injections within one month before RSA. Non-modifiable factors included a history of previous shoulder surgery, inflammatory arthritis, male sex, and younger age.
Conclusion
Proactive management of modifiable risk factors and careful consideration of non-modifiable factors are essential in reducing PJIs after primary RSA. Strategies such as optimizing systemic health conditions and implementing meticulous surgical techniques may contribute to improved outcomes and reduced infection rates in RSA patients.
期刊介绍:
Journal of Clinical Orthopaedics and Trauma (JCOT) aims to provide its readers with the latest clinical and basic research, and informed opinions that shape today''s orthopedic practice, thereby providing an opportunity to practice evidence-based medicine. With contributions from leading clinicians and researchers around the world, we aim to be the premier journal providing an international perspective advancing knowledge of the musculoskeletal system. JCOT publishes content of value to both general orthopedic practitioners and specialists on all aspects of musculoskeletal research, diagnoses, and treatment. We accept following types of articles: • Original articles focusing on current clinical issues. • Review articles with learning value for professionals as well as students. • Research articles providing the latest in basic biological or engineering research on musculoskeletal diseases. • Regular columns by experts discussing issues affecting the field of orthopedics. • "Symposia" devoted to a single topic offering the general reader an overview of a field, but providing the specialist current in-depth information. • Video of any orthopedic surgery which is innovative and adds to present concepts. • Articles emphasizing or demonstrating a new clinical sign in the art of patient examination is also considered for publication. Contributions from anywhere in the world are welcome and considered on their merits.